
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
The UK and Ireland's premier event covering all aspects of the pharmaceutical supply chain.
Dates: April 29–30, 2025
Location: Coventry, UK
Description: The UK and Ireland's premier event covering all aspects of the pharmaceutical supply chain.
Registration:






